Boletín Médico del Hospital Infantil de México (May 2017)

Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine

  • Ana Laura Guzmán-Ortiz,
  • Gerardo Aparicio-Ozores,
  • Ricardo Valle-Rios,
  • Oscar Medina-Contreras,
  • Genaro Patiño-López,
  • Héctor Quezada

DOI
https://doi.org/10.1016/j.bmhimx.2017.03.005
Journal volume & issue
Vol. 74, no. 3
pp. 181 – 192

Abstract

Read online

Introduction: Relapse occurs in approximately 20% of Mexican patients with childhood acute lymphoblastic leukemia (ALL). In this group, chemoresistance may be one of the biggest challenges. An overview of complex cellular processes like drug tolerance can be achieved with proteomic studies. Methods: The B-lineage pediatric ALL cell line CCRF-SB was gradually exposed to the chemotherapeutic vincristine until proliferation was observed at 6 nM, control cells were cultured in the absence of vincristine. The proteome from each group was analyzed by nanoHPLC coupled to an ESI-ion trap mass spectrometer. The identified proteins were grouped into overrepresented functional categories with the PANTHER classification system. Results: We found 135 proteins exclusively expressed in the presence of vincristine. The most represented functional categories were: Toll receptor signaling pathway, Ras Pathway, B and T cell activation, CCKR signaling map, cytokine-mediated signaling pathway, and oxidative phosphorylation. Conclusions: Our study indicates that signal transduction and mitochondrial ATP production are essential during adaptation of leukemic cells to vincristine, these processes represent potential therapeutic targets.

Keywords